PDL BioPharma Stock Price - PDLI

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
PDL BioPharma Inc PDLI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 2.15 0.00 0.00 0.00 2.15 04:00:00
Bid Price Ask Price Spread Spread % News
2.00 2.40 0.40 16.67% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

PDL BioPharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 245.54M 114.20M $ -68.86M -0.46 8.40 107.10M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

PDL BioPharma News

Loading Messages....

Latest PDLI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PDLI Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week2.362.372.152.21182M-0.21-8.90%
1 Month2.542.542.152.31411M-0.39-15.35%
3 Months3.073.352.152.65001M-0.92-29.97%
6 Months3.693.892.153.00491M-1.54-41.73%
1 Year2.453.892.153.01481M-0.3-12.24%
3 Years3.293.891.932.74752M-1.14-34.65%
5 Years7.988.61.934.17142M-5.83-73.06%

PDL BioPharma Description

PDL BioPharma Inc acquires and manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. The operating segments of the company are Pharmaceutical and Medical Devices, of which key revenue is derived from the Pharmaceutical segment. The Pharmaceutical segment consists of revenue derived from branded prescription medicine products sold under the name Tekturna and Tekturna HCT in the U.S, and Rasilez and Rasilez HCT in the rest of the world (collectively, the Noden Products). Geographically, the company operates in Europe, North America, Asia and Other countries, of which prime revenue is generated from Asia and North America.

Your Recent History
PDL BioPha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.